… This clinical entity is called acquired haemophilia. It should be suspected in subjects with …
about it by many specialists, the frequent use of anticoagulant or antiplatelet therapies in the …

… range 9–34) duration of prophylaxis. Eight patients of the … prophylaxis with aPCC effective
and well tolerated for patients with AHA and serious bleeding tendency, until the acquired …

… of the National Haemophilia Foundation [9] recommended that prophylaxis be considered …
children with severe haemophilia A and B. Despite the increasing use of prophylaxis in many …

… Acquired Haemophilia A is a rare acquired bleeding disorder caused by Factor VIII … These
inhibitors differ from alloantibodies against FVIII, which can occur in congenital Haemophilia A …

… of prophylaxis in boys and advising on the role of prophylaxis in … of prophylaxis in children
with SHA. It addresses the optimum use of prophylaxis in children and adults with haemophilia …

… in the treatment of minor bleeding episodes or prophylaxis of minor surgical/invasive
procedures in patients with acquired haemophilia A with a low inhibitor titre and measurable …

… The aim of this paper is to discuss factors that influence choices in establishing prophylaxis
in children with severe or moderate haemophilia A younger than 12 years and to provide …

… risk of recurrence and relapses of bleeding in patients presenting acquired haemophilia.
In a previous Italian study [5] a short-term prophylaxis with lower doses of aPCC, after first-line …

… This disorder is called acquired haemophilia. This is a rare disease, although its impact may
… identifying patients under suspicion of acquired haemophilia to correctly manage them and …

… Nordic countries recommend prophylaxis for PWH with baseline FVIII/FIX ≤.03 IU/mL from
… , prophylaxis is not standard practice for these PWH. This paper reviews prophylactic use of …